Ian Wolf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ian Wolf has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Aurora Pop-Vicas
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
1 shared publication - Lucas T. Schulz
Department of Pharmacy, University of Wisconsin Health, Madison, Wisconsin
1 shared publication - Michael S. Pulia
BerbeeWalsh Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin; Department of Industrial and Systems Engineering, University of Wisconsin-Madison School of Engineering, Madison, Wisconsin
1 shared publication - Peter K. Lindenauer
Department of Healthcare Delivery and Population Sciences, University of Massachusetts Chan Medical School-Baystate, Springfield, MA, United States
1 shared publication - Rebecca J. Schwei
BerbeeWalsh Department of Emergency Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin
1 shared publication
Latest Publications
- Open Access
- 7 August 2020
- Published by Western Journal of Emergency Medicine in Western Journal of Emergency Medicine
- Vol. 21 (5) , 1283-1286
COVID-19: An Emerging Threat to Antibiotic Stewardship in the Emergency Department
While current research efforts focus primarily on identifying patient level interventions that mitigate the direct impact of COVID-19, it is important to consider the collateral effects of COVID-19 on antimicrobial resistance. Early reports suggest high rates of antibiotic utilization in COVID-19 patients despite their lack of direct activity against viral pathogens. The ongoing pandemic is exacerbating known barriers to optimal antibiotic stewardship in the ED, representing an additional direct threat to patient safety and public health. There is an urgent need for research analyzing overall and COVID-19 specific antibiotic prescribing trends in the ED. Optimizing ED stewardship during COVID-19 will likely require a combination of traditional stewardship approaches (e.g. academic detailing, provider education, care pathways) and effective implementation of host response biomarkers and rapid COVID-19 diagnostics. Antibiotic stewardship interventions with demonstrated efficacy in mitigating the impact of COVID-19 on ED prescribing should be widely disseminated and inform the ongoing pandemic response.
- 7 August 2020
- Published by Western Journal of Emergency Medicine in Western Journal of Emergency Medicine
- Vol. 21 (5) , 1283-1286
Open AccessCOVID-19: An Emerging Threat to Antibiotic Stewardship in the Emergency Department
While current research efforts focus primarily on identifying patient level interventions that mitigate the direct impact of COVID-19, it is important to consider the collateral effects of COVID-19 on antimicrobial resistance. Early reports suggest high rates of antibiotic utilization in COVID-19 patients despite their lack of direct activity against viral pathogens. The ongoing pandemic is exacerbating known barriers to optimal antibiotic stewardship in the ED, representing an additional direct threat to patient safety and public health. There is an urgent need for research analyzing overall and COVID-19 specific antibiotic prescribing trends in the ED. Optimizing ED stewardship during COVID-19 will likely require a combination of traditional stewardship approaches (e.g. academic detailing, provider education, care pathways) and effective implementation of host response biomarkers and rapid COVID-19 diagnostics. Antibiotic stewardship interventions with demonstrated efficacy in mitigating the impact of COVID-19 on ED prescribing should be widely disseminated and inform the ongoing pandemic response.